A viral video circulating on social media Sunday appeared to show agitators interfering with an Immigration and Customs Enforcement (ICE) operation targeting an alleged child sex offender in Minnesota ...

The incidence of sudden cardiac arrest in athletes varies according to age, race and ethnic group, sex, sport, and social determinants of health. The common causes of sudden cardiac arrest include ...

Jan 10 (Reuters) - Elon Musk said on Saturday that social media platform X will open to the public its new algorithm, including all code for organic and advertising post recommendations, in seven days ...

While the creation of this new entity marks a big step toward avoiding a U.S. ban, as well as easing trade and tech-related tensions between Washington and Beijing, there is still uncertainty ...

Instagram is introducing a new tool that lets you see and control your algorithm, starting with Reels, the company announced on Wednesday. The new tool, called “Your Algorithm,” lets you view the ...

Fintel reports that on September 26, 2025, Goldman Sachs downgraded their outlook for Apellis Pharmaceuticals (NasdaqGS:APLS) from Neutral to Sell. Analyst Price Forecast Suggests 72.10% Upside As of ...

A California International Marathon runner is recovering after suffering a sudden cardiac arrest during the race, the Sacramento Metropolitan Fire District said on Sunday. The runner, identified as a ...

Please provide your email address to receive an email when new articles are posted on . Bystander CPR performed within the first 5 minutes of a cardiac arrest in children can nearly double their ...

Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Apellis Pharmaceuticals Third Quarter 2025 Earnings Conference Call. Please be advised that today's conference is ...

“I'm kind of paying it forward,” Ethan King said Ethan King An 18-year-old college student suffered cardiac arrest and almost died while running in a park in Michigan A year later, the young man has ...

Fintel reports that on October 15, 2025, Wells Fargo upgraded their outlook for Apellis Pharmaceuticals (NasdaqGS:APLS) from Equal-Weight to Overweight. Analyst Price Forecast Suggests 64.49% Upside ...

Apellis Pharmaceuticals (NASDAQ:APLS) traded lower on Friday after Goldman Sachs downgraded the company to Sell from Neutral, citing risks to its outlook and handing the eye drug developer its only ...